Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 478 entries
Sorted by: Best Match Show Resources per page
Effect of Electrode Distance in Grid Electrode: Numerical Models and In Vitro Tests.

Technology in cancer research & treatment

Ongaro A, Campana LG, De Mattei M, Di Barba P, Dughiero F, Forzan M, Mognaschi ME, Pellati A, Rossi CR, Bernardello C, Sieni E.
PMID: 29558871
Technol Cancer Res Treat. 2018 Jan 01;17:1533033818764498. doi: 10.1177/1533033818764498.

Electrochemotherapy is an emerging local treatment for the management of superficial tumors and, among these, also chest wall recurrences from breast cancer. Generally, the treatment of this peculiar type of tumor requires the coverage of large skin areas. In...

Cite
Ongaro A, Campana LG, De Mattei M, et al. Effect of Electrode Distance in Grid Electrode: Numerical Models and In Vitro Tests. Technol Cancer Res Treat. 2018;17:1533033818764498doi: 10.1177/1533033818764498.
Ongaro, A., Campana, L. G., De Mattei, M., Di Barba, P., Dughiero, F., Forzan, M., Mognaschi, M. E., Pellati, A., Rossi, C. R., Bernardello, C., & Sieni, E. (2018). Effect of Electrode Distance in Grid Electrode: Numerical Models and In Vitro Tests. Technology in cancer research & treatment, 171533033818764498. https://doi.org/10.1177/1533033818764498
Ongaro, Alessia, et al. "Effect of Electrode Distance in Grid Electrode: Numerical Models and In Vitro Tests." Technology in cancer research & treatment vol. 17 (2018): 1533033818764498. doi: https://doi.org/10.1177/1533033818764498
Ongaro A, Campana LG, De Mattei M, Di Barba P, Dughiero F, Forzan M, Mognaschi ME, Pellati A, Rossi CR, Bernardello C, Sieni E. Effect of Electrode Distance in Grid Electrode: Numerical Models and In Vitro Tests. Technol Cancer Res Treat. 2018 Jan 01;17:1533033818764498. doi: 10.1177/1533033818764498. PMID: 29558871; PMCID: PMC5863864.
Copy Download .nbib Format: NLM
Use of apparent diffusion coefficient images to predict response to induction chemotherapy in sinonasal cancer.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Bologna M, Montin E, Corino VDA, Bossi P, Calareso G, Licitra L, Mainardi LT.
PMID: 30440511
Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:782-785. doi: 10.1109/EMBC.2018.8512306.

The purpose of this study is to identify a set of radiomic features extracted from apparent diffusion coefficient (ADC) maps, obtained using baseline diffusion weighted magnetic resonance imaging (DW-MRI), which are able to predict the outcome of induction chemotherapy...

Cite
Bologna M, Montin E, Corino VDA, et al. Use of apparent diffusion coefficient images to predict response to induction chemotherapy in sinonasal cancer. Annu Int Conf IEEE Eng Med Biol Soc. 2018;2018:782-785doi: 10.1109/EMBC.2018.8512306.
Bologna, M., Montin, E., Corino, V. D. A., Bossi, P., Calareso, G., Licitra, L., & Mainardi, L. T. (2018). Use of apparent diffusion coefficient images to predict response to induction chemotherapy in sinonasal cancer. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2018782-785. https://doi.org/10.1109/EMBC.2018.8512306
Bologna, Marco, et al. "Use of apparent diffusion coefficient images to predict response to induction chemotherapy in sinonasal cancer." Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference vol. 2018 (2018): 782-785. doi: https://doi.org/10.1109/EMBC.2018.8512306
Bologna M, Montin E, Corino VDA, Bossi P, Calareso G, Licitra L, Mainardi LT. Use of apparent diffusion coefficient images to predict response to induction chemotherapy in sinonasal cancer. Annu Int Conf IEEE Eng Med Biol Soc. 2018 Jul;2018:782-785. doi: 10.1109/EMBC.2018.8512306. PMID: 30440511.
Copy Download .nbib Format: NLM
Value-Based Cancer Care.

The New England journal of medicine

Young RC.
PMID: 26580243
N Engl J Med. 2015 Dec 31;373(27):2593-5. doi: 10.1056/NEJMp1508387. Epub 2015 Nov 18.

No abstract available.

Cite
Young RC. Value-Based Cancer Care. N Engl J Med. 2015;373(27):2593-5doi: 10.1056/NEJMp1508387.
Young, R. C. (2015). Value-Based Cancer Care. The New England journal of medicine, 373(27), 2593-5. https://doi.org/10.1056/NEJMp1508387
Young, Robert C. "Value-Based Cancer Care." The New England journal of medicine vol. 373,27 (2015): 2593-5. doi: https://doi.org/10.1056/NEJMp1508387
Young RC. Value-Based Cancer Care. N Engl J Med. 2015 Dec 31;373(27):2593-5. doi: 10.1056/NEJMp1508387. Epub 2015 Nov 18. PMID: 26580243.
Copy Download .nbib Format: NLM
Targeted Therapies in Pediatric Oncology.

Drug research

Fischer M.
PMID: 30453366
Drug Res (Stuttg). 2018 Nov;68:S14. doi: 10.1055/a-0733-0816. Epub 2018 Nov 19.

No abstract available.

Cite
Fischer M. Targeted Therapies in Pediatric Oncology. Drug Res (Stuttg). 2018;68:S14doi: 10.1055/a-0733-0816.
Fischer, M. (2018). Targeted Therapies in Pediatric Oncology. Drug research, 68S14. https://doi.org/10.1055/a-0733-0816
Fischer, Matthias. "Targeted Therapies in Pediatric Oncology." Drug research vol. 68 (2018): S14. doi: https://doi.org/10.1055/a-0733-0816
Fischer M. Targeted Therapies in Pediatric Oncology. Drug Res (Stuttg). 2018 Nov;68:S14. doi: 10.1055/a-0733-0816. Epub 2018 Nov 19. PMID: 30453366.
Copy Download .nbib Format: NLM
Effects of Exercise During or Postchemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis.

Worldviews on evidence-based nursing

Zeng J, Wu J, Tang C, Xu N, Lu L.
PMID: 30854763
Worldviews Evid Based Nurs. 2019 Apr;16(2):92-101. doi: 10.1111/wvn.12341. Epub 2019 Mar 10.

BACKGROUND: Exercise may effectively reduce side effects caused by chemotherapy. However, no meta-analyses of exercise during or postchemotherapy for cancer patients have been definitely performed to guide clinical practice.AIMS: To evaluate and summarize available scientific evidence to provide recommendations...

Cite
Zeng J, Wu J, Tang C, et al. Effects of Exercise During or Postchemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis. Worldviews Evid Based Nurs. 2019;16(2):92-101doi: 10.1111/wvn.12341.
Zeng, J., Wu, J., Tang, C., Xu, N., & Lu, L. (2019). Effects of Exercise During or Postchemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis. Worldviews on evidence-based nursing, 16(2), 92-101. https://doi.org/10.1111/wvn.12341
Zeng, Jingchun, et al. "Effects of Exercise During or Postchemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis." Worldviews on evidence-based nursing vol. 16,2 (2019): 92-101. doi: https://doi.org/10.1111/wvn.12341
Zeng J, Wu J, Tang C, Xu N, Lu L. Effects of Exercise During or Postchemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis. Worldviews Evid Based Nurs. 2019 Apr;16(2):92-101. doi: 10.1111/wvn.12341. Epub 2019 Mar 10. PMID: 30854763.
Copy Download .nbib Format: NLM
[Research progress on the immune checkpoint inhibitors induced cardiotoxicity].

Zhonghua xin xue guan bing za zhi

Lyu SS, Yang YM.
PMID: 31550849
Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Sep 24;47(9):748-751. doi: 10.3760/cma.j.issn.0253-3758.2019.09.019.

No abstract available.

Cite
Lyu SS, Yang YM. [Research progress on the immune checkpoint inhibitors induced cardiotoxicity]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019;47(9):748-751doi: 10.3760/cma.j.issn.0253-3758.2019.09.019.
Lyu, S. S., & Yang, Y. M. (2019). [Research progress on the immune checkpoint inhibitors induced cardiotoxicity]. Zhonghua xin xue guan bing za zhi, 47(9), 748-751. https://doi.org/10.3760/cma.j.issn.0253-3758.2019.09.019
Lyu, S S, and Yang, Y M. "[Research progress on the immune checkpoint inhibitors induced cardiotoxicity]." Zhonghua xin xue guan bing za zhi vol. 47,9 (2019): 748-751. doi: https://doi.org/10.3760/cma.j.issn.0253-3758.2019.09.019
Lyu SS, Yang YM. [Research progress on the immune checkpoint inhibitors induced cardiotoxicity]. Zhonghua Xin Xue Guan Bing Za Zhi. 2019 Sep 24;47(9):748-751. doi: 10.3760/cma.j.issn.0253-3758.2019.09.019. Chinese. PMID: 31550849.
Copy Download .nbib Format: NLM
New clinical trial designs in the era of precision medicine.

Molecular oncology

Garralda E, Dienstmann R, Piris-Giménez A, Braña I, Rodon J, Tabernero J.
PMID: 30698321
Mol Oncol. 2019 Mar;13(3):549-557. doi: 10.1002/1878-0261.12465. Epub 2019 Feb 22.

Cancer treatment has made significant strides towards the promise of personalized medicine. Recent scientific advances have shown that there are numerous genetic deregulations that are common in multiple cancer types, raising the possibility of developing drugs targeting those deregulations...

Cite
Garralda E, Dienstmann R, Piris-Giménez A, et al. New clinical trial designs in the era of precision medicine. Mol Oncol. 2019;13(3):549-557doi: 10.1002/1878-0261.12465.
Garralda, E., Dienstmann, R., Piris-Giménez, A., Braña, I., Rodon, J., & Tabernero, J. (2019). New clinical trial designs in the era of precision medicine. Molecular oncology, 13(3), 549-557. https://doi.org/10.1002/1878-0261.12465
Garralda, Elena, et al. "New clinical trial designs in the era of precision medicine." Molecular oncology vol. 13,3 (2019): 549-557. doi: https://doi.org/10.1002/1878-0261.12465
Garralda E, Dienstmann R, Piris-Giménez A, Braña I, Rodon J, Tabernero J. New clinical trial designs in the era of precision medicine. Mol Oncol. 2019 Mar;13(3):549-557. doi: 10.1002/1878-0261.12465. Epub 2019 Feb 22. PMID: 30698321; PMCID: PMC6396357.
Copy Download .nbib Format: NLM
Documentation of medical marijuana use in cancer patients.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

LeClair JN, Chamberlin KW, Clement J, Holle LM.
PMID: 31707922
J Oncol Pharm Pract. 2020 Jul;26(5):1117-1127. doi: 10.1177/1078155219883912. Epub 2019 Nov 10.

PURPOSE: Medical marijuana is often used as adjuvant therapy in cancer patients for symptom management, although limited evidence-based studies evaluating its efficacy or safety exist. Similar to over-the-counter medications, supplements, or herbal products, documentation of medical marijuana is important...

Cite
LeClair JN, Chamberlin KW, Clement J, et al. Documentation of medical marijuana use in cancer patients. J Oncol Pharm Pract. 2019;26(5):1117-1127doi: 10.1177/1078155219883912.
LeClair, J. N., Chamberlin, K. W., Clement, J., & Holle, L. M. (2020). Documentation of medical marijuana use in cancer patients. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 26(5), 1117-1127. https://doi.org/10.1177/1078155219883912
LeClair, Jessica N, et al. "Documentation of medical marijuana use in cancer patients." Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners vol. 26,5 (2020): 1117-1127. doi: https://doi.org/10.1177/1078155219883912
LeClair JN, Chamberlin KW, Clement J, Holle LM. Documentation of medical marijuana use in cancer patients. J Oncol Pharm Pract. 2020 Jul;26(5):1117-1127. doi: 10.1177/1078155219883912. Epub 2019 Nov 10. PMID: 31707922.
Copy Download .nbib Format: NLM
Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials.

JAMA oncology

Roydhouse JK, Fiero MH, Kluetz PG.
PMID: 30653227
JAMA Oncol. 2019 Apr 01;5(4):457-458. doi: 10.1001/jamaoncol.2018.6205.

No abstract available.

Cite
Roydhouse JK, Fiero MH, Kluetz PG. Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials. JAMA Oncol. 2019;5(4):457-458doi: 10.1001/jamaoncol.2018.6205.
Roydhouse, J. K., Fiero, M. H., & Kluetz, P. G. (2019). Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials. JAMA oncology, 5(4), 457-458. https://doi.org/10.1001/jamaoncol.2018.6205
Roydhouse, Jessica K, et al. "Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials." JAMA oncology vol. 5,4 (2019): 457-458. doi: https://doi.org/10.1001/jamaoncol.2018.6205
Roydhouse JK, Fiero MH, Kluetz PG. Investigating Potential Bias in Patient-Reported Outcomes in Open-label Cancer Trials. JAMA Oncol. 2019 Apr 01;5(4):457-458. doi: 10.1001/jamaoncol.2018.6205. PMID: 30653227.
Copy Download .nbib Format: NLM
How biosimilars will impact costs and care in oncology.

Clinical advances in hematology & oncology : H&O

Lyman GH.
PMID: 31730579
Clin Adv Hematol Oncol. 2019 Oct;17(10):544-547.

No abstract available.

Cite
Lyman GH. How biosimilars will impact costs and care in oncology. Clin Adv Hematol Oncol. 2019;17(10):544-547
Lyman, G. H. (2019). How biosimilars will impact costs and care in oncology. Clinical advances in hematology & oncology : H&O, 17(10), 544-547.
Lyman, Gary H. "How biosimilars will impact costs and care in oncology." Clinical advances in hematology & oncology : H&O vol. 17,10 (2019): 544-547.
Lyman GH. How biosimilars will impact costs and care in oncology. Clin Adv Hematol Oncol. 2019 Oct;17(10):544-547. PMID: 31730579.
Copy Download .nbib Format: NLM
Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey.

Journal of global oncology

Cohen P, Friedrich P, Lam C, Jeha S, Metzger ML, Qaddoumi I, Naidu P, Faughnan L, Rodriguez-Galindo C, Bhakta N.
PMID: 30582430
J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00150.

PURPOSE: Global data mapping access to essential chemotherapeutics for pediatric cancer are scarce. We report a survey of international pediatric cancer care providers' access to these medicines.METHODS: A Web-based survey was sent to pediatric oncologists registered on the Cure4Kids...

Cite
Cohen P, Friedrich P, Lam C, et al. Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey. J Glob Oncol. 2018;4:1-11doi: 10.1200/JGO.18.00150.
Cohen, P., Friedrich, P., Lam, C., Jeha, S., Metzger, M. L., Qaddoumi, I., Naidu, P., Faughnan, L., Rodriguez-Galindo, C., & Bhakta, N. (2018). Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey. Journal of global oncology, 41-11. https://doi.org/10.1200/JGO.18.00150
Cohen, Phillip, et al. "Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey." Journal of global oncology vol. 4 (2018): 1-11. doi: https://doi.org/10.1200/JGO.18.00150
Cohen P, Friedrich P, Lam C, Jeha S, Metzger ML, Qaddoumi I, Naidu P, Faughnan L, Rodriguez-Galindo C, Bhakta N. Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey. J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00150. PMID: 30582430; PMCID: PMC7010437.
Copy Download .nbib Format: NLM
Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers.

Nanomedicine (London, England)

Viswanadh MK, Muthu MS.
PMID: 29972678
Nanomedicine (Lond). 2018 Jun;13(12):1401-1403. doi: 10.2217/nnm-2018-0114. Epub 2018 Jul 04.

No abstract available.

Cite
Viswanadh MK, Muthu MS. Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers. Nanomedicine (Lond). 2018;13(12):1401-1403doi: 10.2217/nnm-2018-0114.
Viswanadh, M. K., & Muthu, M. S. (2018). Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers. Nanomedicine (London, England), 13(12), 1401-1403. https://doi.org/10.2217/nnm-2018-0114
Viswanadh, Matte Kasi, and Muthu, Madaswamy S. "Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers." Nanomedicine (London, England) vol. 13,12 (2018): 1401-1403. doi: https://doi.org/10.2217/nnm-2018-0114
Viswanadh MK, Muthu MS. Targeted bioadhesive nanomedicine: an effective approach for synergistic drug delivery to cancers. Nanomedicine (Lond). 2018 Jun;13(12):1401-1403. doi: 10.2217/nnm-2018-0114. Epub 2018 Jul 04. PMID: 29972678.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 478 entries